완전관해 후 중추신경계에 재발한 골수외 형질세포종
Relapsed plasmacytoma in central nervous system after complete remission of extramedullary plasmacytoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Extramedullary plasmacytoma (EMP) is a rare disease that occurs in 3% to 5% of patients with plasma cell disorder. It occurs most commonly in the upper respiratory tract and the oral cavity. Very few EMP cases have been reported in the central nervous system (CNS). We report herein an unusual case of EMP in the nasal cavity that recurred in the CNS without systemic involvement. A 67-year-old man visited our hospital due to a month-long bout with exophthalmos. He was diagnosed with EMP in the nasal cavity, paranasal sinus, and orbital cavity. He received radiotherapy to which he had complete responses. After 2 years, he visited our hospital because of a month-long headache. He was diagnosed with EMP recurrence in the CNS via brain magnetic resonance imaging and cerebrospinal fluid analysis. He was treated with whole brain radiotherapy and intrathecal chemotherapy with methotrexate, but he expired due to pneumonia.
Abstract
Extramedullary plasmacytoma (EMP) is a rare disease that occurs in 3% to 5% of patients with plasma cell disorder. It occurs most commonly in the upper respiratory tract and the oral cavity. Very few EMP cases have been reported in the central nervous system (CNS). We report herein an unusual case of EMP in the nasal cavity that recurred in the CNS without systemic involvement. A 67-year-old man visited our hospital due to a month-long bout with exophthalmos. He was diagnosed with EMP in the nasal cavity, paranasal sinus, and orbital cavity. He received radiotherapy to which he had complete responses. After 2 years, he visited our hospital because of a month-long headache. He was diagnosed with EMP recurrence in the CNS via brain magnetic resonance imaging and cerebrospinal fluid analysis. He was treated with whole brain radiotherapy and intrathecal chemotherapy with methotrexate, but he expired due to pneumonia.
참고문헌 (14)
- Alexiou C, "Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts", Cancer, 85, pp.2305~2314 (1999)
- Galieni P, "Clinical outcome of extramedullary plasmacytoma", Haematologica, 85, pp.47~51 (2000)
- Liebross RH, "Clinical course of solitary extramedullary plasmacytoma", Radiother Oncol, 52, pp.245~249 (1999)
- Bolek TW, "Solitary plasmacytoma of bone and soft tissue", Int J Radiat Oncol Biol Phys, 36, pp.329~333 (1996)
- Schridde H, "Weitere Untersuchungen uber die Kornelungen der Plasmazellen", Centralbl Allg Pathol Pathol Anat, 16, pp.433~435 (1905)
- International Myeloma Working Group, "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group", Br J Haematol, 121, pp.749~757 (2003)
- Baumgartner BR, "Extramedullary plasmacytoma of the colon", Am J Gastroenterol, 80, pp.1017~1019 (1985)
- Nolan KD, "Plasma cell neoplasms. review of disease progression and report of a new variant", Surg Oncol, 14, pp.85~90 (2005)
- Wu W, "Extraosseous plasmacytoma with an aggressive course occurring solely in the CNS", Neuropathology, 33, pp.320~323 (2013)
- Hansen PB, "Successful treatment of posttransplant EBV-associated lymphoma and plasmacytoma solely localized to the CNS", Case Rep Hematol, 2012, pp.497614~ (2012)
- Au WY, "Treatment of postrenal transplantation lymphoproliferative disease manifesting as plasmacytoma with nonmyeloablative hematopoietic stem cell transplantation from the same kidney donor", Am J Hematol, 74, pp.283~286 (2003)
- 이수현, "두개 내를 침범한 형질세포골수종 1예", Yeungnam University Journal of Medicine, 29(1), pp.42~44 (2012), 영남대학교 의과대학
- Fassas AB, "Myeloma of the central nervous system:association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations", Br J Haematol, 117, pp.103~108 (2002)
- Chen CI, "Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents", Br J Haematol, 162, pp.483~488 (2013)